(RTTNews) - Acadia Pharmaceuticals Inc. (ACAD) announced that the FDA has approved DAYBUE STIX for oral solution for the treatment of Rett syndrome in adult and pediatric patients two years of age and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback